Save
Email
Print
Share
RSSBrowse News Stories
21 to 30 of 76 stories
view headlines only
-
Combining NSAIDs With Chemotherapy, Radiation May Improve Cancer Treatment
May 17, 2007 — Certain nonsteroidal anti-inflammatory drugs may be better suited to treating cancer, in combination with standard therapies, rather than preventing it, according to new ... > full story -
FDA Causes Unnecessary Scare About Common Painkillers, Says Doctor
April 24, 2007 — The US Food and Drug Administration has caused an unnecessary scare about some pain relievers by adding a warning to drugs that are safe, says Curt Furberg, M.D., Ph.D., from Wake Forest University ... > full story -
Green Tea And COX-2 Inhibitors Combine To Slow Growth Of Prostate Cancer
March 1, 2007 — Drinking a nice warm cup of green tea has long been touted for its healthful benefits, both real and anecdotal. But now researchers have found that a component of green tea, combined with low doses ... > full story -
Engineering The 'Super Enzyme' -- A Potential New Weapon Against Heart Disease
November 28, 2006 — Efforts to understand the link between the cyclooxygenase-2 (COX-2) inhibitor arthritis drugs and heart disease have had an unanticipated benefit in leading to development of an engineered protein ... > full story -
Celecoxib, Naproxen Safety Results Now Published
November 20, 2006 — A paper appearing this week in the Public Library of Science journal PLoS Clinical Trials presents findings from a large National Institutes of Health sponsored trial regarding the cardiovascular and ... > full story -
Doctors Develop New Approach To Web-Based Drug Withdrawal Warnings
September 25, 2006 — The University of Cincinnati has developed a faster approach for informing consumers online when the Food and Drug Administration (FDA) withdraws a medication. Researchers hope this new 24-hour ... > full story -
New Evidence On Risks Associated With Cox-2 Inhibitors And NSAIDs
September 15, 2006 — Two new review studies evaluating the safety of the pain-relieving medications selective cyclooxygenase 2 (COX-2) inhibitors and non-steroidal anti-inflammatory drugs (NSAIDs) find increased ... > full story -
New Type Of Pain Reliever May Benefit The Heart
September 12, 2006 — Researchers at the University of Pennsylvania School of Medicine have found that deleting an inflammation enzyme in a mouse model of heart disease slowed the development of atherosclerosis. What's ... > full story -
New Celebrex Study: Unlocking Colon Cancer With Key Of Prevention
August 30, 2006 — An international team of scientists reports that a single 400-milligram daily dose of celecoxib, commonly called Celebrex and manufactured by Pfizer, significantly reduced recurrence of adenomas -- ... > full story -
Study Finds That Vioxx Reduces The Risk Of Colorectal Polyps
August 30, 2006 — A researcher from Dartmouth reports the results of a clinical trial that shows that the cyclooxygenase-2 inhibitor rofecoxib reduces the risk of colorectal adenomas, or ... > full story
Search ScienceDaily
Number of stories in archives: 140,690
more 
